vs
礼蓝动物保健（ELAN）与Rithm Capital Corp.（RITM）财务数据对比。点击上方公司名可切换其他公司
礼蓝动物保健的季度营收约是Rithm Capital Corp.的1.4倍（$1.1B vs $828.2M），Rithm Capital Corp.净利率更高（13.2% vs -24.1%，领先37.3%），Rithm Capital Corp.同比增速更快（508.5% vs 12.2%），过去两年礼蓝动物保健的营收复合增速更高（-2.6% vs -17.9%）
礼蓝动物保健是一家美国动物保健制药企业，专注于生产宠物及家畜用药品与疫苗。该公司原为礼来公司旗下子公司，2019年完成分拆独立，目前是全球第三大动物保健企业。
Rithm Capital Corp.是总部位于美国纽约的投资管理机构，核心业务聚焦房地产投资与另类资产投资，依托专业的投研团队和成熟的市场运营经验，为合作伙伴及投资者提供优质的资产配置解决方案与长期收益回报。
ELAN vs RITM — 直观对比
营收规模更大
ELAN
是对方的1.4倍
$828.2M
营收增速更快
RITM
高出496.3%
12.2%
净利率更高
RITM
高出37.3%
-24.1%
两年增速更快
ELAN
近两年复合增速
-17.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $828.2M |
| 净利润 | $-276.0M | $109.5M |
| 毛利率 | 51.5% | — |
| 营业利润率 | -22.6% | 29.9% |
| 净利率 | -24.1% | 13.2% |
| 营收同比 | 12.2% | 508.5% |
| 净利润同比 | -3350.0% | 27.7% |
| 每股收益（稀释后） | $-0.55 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELANRITM
| Q1 26 | — | $828.2M | ||
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.2B | $768.4M | ||
| Q4 24 | $1.0B | $2.1B | ||
| Q3 24 | $1.0B | $619.5M | ||
| Q2 24 | $1.2B | $1.2B |
净利润ELANRITM
| Q1 26 | — | $109.5M | ||
| Q4 25 | $-276.0M | $85.0M | ||
| Q3 25 | $-34.0M | $221.5M | ||
| Q2 25 | $11.0M | $311.7M | ||
| Q1 25 | $67.0M | $78.8M | ||
| Q4 24 | $-8.0M | $290.2M | ||
| Q3 24 | $364.0M | $121.7M | ||
| Q2 24 | $-50.0M | $235.6M |
毛利率ELANRITM
| Q1 26 | — | — | ||
| Q4 25 | 51.5% | — | ||
| Q3 25 | 53.4% | — | ||
| Q2 25 | 57.5% | — | ||
| Q1 25 | 57.3% | — | ||
| Q4 24 | 50.9% | — | ||
| Q3 24 | 52.2% | — | ||
| Q2 24 | 58.2% | — |
营业利润率ELANRITM
| Q1 26 | — | 29.9% | ||
| Q4 25 | -22.6% | 13.8% | ||
| Q3 25 | -4.4% | 21.4% | ||
| Q2 25 | 2.0% | 25.2% | ||
| Q1 25 | 5.0% | 7.4% | ||
| Q4 24 | -5.0% | 23.8% | ||
| Q3 24 | 54.3% | 7.3% | ||
| Q2 24 | -2.7% | 23.6% |
净利率ELANRITM
| Q1 26 | — | 13.2% | ||
| Q4 25 | -24.1% | 5.7% | ||
| Q3 25 | -3.0% | 20.0% | ||
| Q2 25 | 0.9% | 25.6% | ||
| Q1 25 | 5.6% | 10.3% | ||
| Q4 24 | -0.8% | 14.0% | ||
| Q3 24 | 35.3% | 19.7% | ||
| Q2 24 | -4.2% | 19.2% |
每股收益（稀释后）ELANRITM
| Q1 26 | — | $0.12 | ||
| Q4 25 | $-0.55 | $0.09 | ||
| Q3 25 | $-0.07 | $0.35 | ||
| Q2 25 | $0.02 | $0.53 | ||
| Q1 25 | $0.13 | $0.07 | ||
| Q4 24 | $-0.01 | $0.50 | ||
| Q3 24 | $0.73 | $0.20 | ||
| Q2 24 | $-0.10 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $545.0M | — |
| 总债务越低越好 | $3.9B | — |
| 股东权益账面价值 | $6.5B | $9.1B |
| 总资产 | $13.4B | $53.4B |
| 负债/权益比越低杠杆越低 | 0.60× | — |
8季度趋势，按日历期对齐
现金及短期投资ELANRITM
| Q1 26 | — | — | ||
| Q4 25 | $545.0M | $1.8B | ||
| Q3 25 | $505.0M | $1.6B | ||
| Q2 25 | $539.0M | $1.6B | ||
| Q1 25 | $487.0M | $1.5B | ||
| Q4 24 | $468.0M | $1.5B | ||
| Q3 24 | $490.0M | $1.6B | ||
| Q2 24 | $416.0M | $1.2B |
总债务ELANRITM
| Q1 26 | — | — | ||
| Q4 25 | $3.9B | $35.4B | ||
| Q3 25 | $4.0B | $32.2B | ||
| Q2 25 | $4.1B | $31.2B | ||
| Q1 25 | $4.4B | $32.2B | ||
| Q4 24 | $4.3B | $32.6B | ||
| Q3 24 | $4.4B | $29.6B | ||
| Q2 24 | $5.7B | $30.1B |
股东权益ELANRITM
| Q1 26 | — | $9.1B | ||
| Q4 25 | $6.5B | $8.4B | ||
| Q3 25 | $6.7B | $8.5B | ||
| Q2 25 | $6.8B | $7.9B | ||
| Q1 25 | $6.4B | $7.8B | ||
| Q4 24 | $6.1B | $7.8B | ||
| Q3 24 | $6.5B | $7.7B | ||
| Q2 24 | $5.9B | $7.3B |
总资产ELANRITM
| Q1 26 | — | $53.4B | ||
| Q4 25 | $13.4B | $53.1B | ||
| Q3 25 | $13.6B | $47.2B | ||
| Q2 25 | $13.7B | $44.3B | ||
| Q1 25 | $12.9B | $45.3B | ||
| Q4 24 | $12.6B | $46.0B | ||
| Q3 24 | $13.3B | $42.3B | ||
| Q2 24 | $13.8B | $42.0B |
负债/权益比ELANRITM
| Q1 26 | — | — | ||
| Q4 25 | 0.60× | 4.20× | ||
| Q3 25 | 0.59× | 3.79× | ||
| Q2 25 | 0.61× | 3.92× | ||
| Q1 25 | 0.69× | 4.14× | ||
| Q4 24 | 0.70× | 4.18× | ||
| Q3 24 | 0.67× | 3.87× | ||
| Q2 24 | 0.96× | 4.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $108.0M | — |
| 自由现金流经营现金流 - 资本支出 | $46.0M | — |
| 自由现金流率自由现金流/营收 | 4.0% | — |
| 资本支出强度资本支出/营收 | 5.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $284.0M | — |
8季度趋势，按日历期对齐
经营现金流ELANRITM
| Q1 26 | — | — | ||
| Q4 25 | $108.0M | $-114.6M | ||
| Q3 25 | $219.0M | $-2.0B | ||
| Q2 25 | $237.0M | $-557.1M | ||
| Q1 25 | $-4.0M | $1.4B | ||
| Q4 24 | $177.0M | $-1.8B | ||
| Q3 24 | $162.0M | $768.1M | ||
| Q2 24 | $200.0M | $-55.7M |
自由现金流ELANRITM
| Q1 26 | — | — | ||
| Q4 25 | $46.0M | — | ||
| Q3 25 | $127.0M | — | ||
| Q2 25 | $180.0M | — | ||
| Q1 25 | $-69.0M | — | ||
| Q4 24 | $130.0M | — | ||
| Q3 24 | $120.0M | — | ||
| Q2 24 | $166.0M | — |
自由现金流率ELANRITM
| Q1 26 | — | — | ||
| Q4 25 | 4.0% | — | ||
| Q3 25 | 11.2% | — | ||
| Q2 25 | 14.5% | — | ||
| Q1 25 | -5.8% | — | ||
| Q4 24 | 12.7% | — | ||
| Q3 24 | 11.7% | — | ||
| Q2 24 | 14.0% | — |
资本支出强度ELANRITM
| Q1 26 | — | — | ||
| Q4 25 | 5.4% | — | ||
| Q3 25 | 8.1% | — | ||
| Q2 25 | 4.6% | — | ||
| Q1 25 | 5.4% | — | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 4.1% | — | ||
| Q2 24 | 2.9% | — |
现金转化率ELANRITM
| Q1 26 | — | — | ||
| Q4 25 | — | -1.35× | ||
| Q3 25 | — | -9.22× | ||
| Q2 25 | 21.55× | -1.79× | ||
| Q1 25 | -0.06× | 18.03× | ||
| Q4 24 | — | -6.04× | ||
| Q3 24 | 0.45× | 6.31× | ||
| Q2 24 | — | -0.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ELAN
| Pet Health | $489.0M | 43% |
| Cattle | $296.0M | 26% |
| Poultry | $237.0M | 21% |
| Swine | $107.0M | 9% |
| Contract Manufacturing | $15.0M | 1% |
RITM
| Servicing revenue, net | $375.1M | 45% |
| Other | $234.9M | 28% |
| Gain on originated residential mortgage loans, held-for-sale, net | $195.0M | 24% |
| Other revenue | $23.3M | 3% |
